FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

31707003: Zinc bacitracin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
52970019 Zinc bacitracin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
52971015 Bacitracin zinc complex en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
52972010 Bacitracin zinc en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
762872015 Zinc bacitracin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2660331000005113 Bacitracinzink da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zinc bacitracin Is a Bacitracin false Inferred relationship Some
Zinc bacitracin Is a Cyclic peptide (substance) true Inferred relationship Some
Zinc bacitracin Is a Antibacterial true Inferred relationship Some
Zinc bacitracin Is a Drug allergen false Inferred relationship Some
Zinc bacitracin This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Bacitracin true Inferred relationship Some
Zinc bacitracin This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
polymyxin B-sulfat + bacitracinzink øjensalve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc bacitracin Inferred relationship Some
polymyxin B-sulfat + bacitracinzink 10.000 enheder/500 enheder øjensalve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc bacitracin Inferred relationship Some
bacitracinzink 400 enheder + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder salve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc bacitracin Inferred relationship Some
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc bacitracin Inferred relationship Some
bacitracinzink 500 enheder + polymyxin B-sulfat 10.000 enheder salve The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc bacitracin Inferred relationship Some
bacitracinzink + neomycinsulfat + polymyxin B-sulfat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc bacitracin Inferred relationship Some
Bacitracin zinc + polymyxin b sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc bacitracin Inferred relationship Some
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate and zinc bacitracin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc bacitracin Inferred relationship Some

This concept is not in any reference sets

Back to Start